RIZATRIPTAN BENZOATE
- Product NDC
- 72189-316
- 11-digit product format
- 721890316
- Labeler code
- 72189
- Product ID
- 72189-316_2c3d1d1c-309d-23dd-e063-6294a90ac2ef
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- RIZATRIPTAN BENZOATE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct Rx
- Application
- ANDA203269
- Marketing category
- ANDA
- Marketing start
- 2022-01-20
- Substance
- RIZATRIPTAN BENZOATE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- RIZATRIPTAN BENZOATE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIZATRIPTAN BENZOATE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | WR978S7QHH |
| Rxcui | 312840 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72189-316-18 | RIZATRIPTAN BENZOATE | 18 in 1 BOTTLE | TABLET | 18 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72189-316 | RIZATRIPTAN BENZOATE TABLET [DIRECT RX] | 2 | Current NDC, Legacy NDC, 1 package rows | 20250122_d60560d5-8e52-099d-e053-2a95a90a20af.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72189-316-18 | 72189031618 | 18 TABLET in 1 BOTTLE (72189-316-18) | 18 tablet | 2022-01-20 | 0000-00-00 | No | No | Current |